Your browser doesn't support javascript.
loading
Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib.
Cesini, Laura; Carmosino, Ida; Breccia, Massimo; De Benedittis, Daniela; Mohamed, Sara; De Luca, Maria Lucia; Colafigli, Gioia; Molica, Matteo; Scalzulli, Emilia; Massaro, Fulvio; Mariggiò, Elena; Rizzo, Lorenzo; Loglisci, Maria Giovanna; Scamuffa, Maria Cristina; Vozella, Federico; Diverio, Daniela; Mancini, Marco; Alimena, Giuliana; Foà, Robin; Latagliata, Roberto.
Afiliação
  • Cesini L; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Carmosino I; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Breccia M; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • De Benedittis D; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Mohamed S; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • De Luca ML; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Colafigli G; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Molica M; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Scalzulli E; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Massaro F; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Mariggiò E; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Rizzo L; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Loglisci MG; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Scamuffa MC; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Vozella F; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Diverio D; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Mancini M; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Alimena G; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Foà R; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Latagliata R; Hematology, Department of Precision and Translational Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy, rob.lati@libero.it.
Oncol Res Treat ; 42(12): 660-664, 2019.
Article em En | MEDLINE | ID: mdl-31593970

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Eritropoetina / Mesilato de Imatinib / Anemia Tipo de estudo: Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Eritropoetina / Mesilato de Imatinib / Anemia Tipo de estudo: Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article